Close Menu

David Hamilton at VentureBeat has an article on XDx, a molecular diagnostic company focusing on gene expression tests, which just filed for an IPO to raise as much as $87 million. The article lays out the case for gene-expression-based diagnostics, but also notes that so far these tests have "been slow to catch on." The article runs through similar existing tests, and gives a nice snapshot of the XDx business.

 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.